MetS is an independent prognostic factor for both OS and PFS of PTCL patients, showing strong prognostic effect. Combining MetS with IPI enables further stratification of patients, and MetS can strongly supplement the existing prognostic scoring systems in the future.
No takes yet. Share an insight, caveat, or question.
Li et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: